Page 10 - Recursion Operating System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recursion Pharmaceuticals Announces Pricing of Initial Public Offering News provided by Share this article Share this article SALT LAKE CITY, April 16, 2021 /PRNewswire/ Recursion Pharmaceuticals, Inc. ( Recursion or we ) today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Recursion, are expected to be $436.4 million, excluding any exercise of the underwriters option to purchase additional shares. The shares are expected to begin trading on the Nasdaq Global Select Market on April 16, 2021 under the symbol RXRX and the offering is expected to close on April 20, 2021, subject to customary closing conditions. In addition, Recursion has granted the underwriters a 30-day option to purchase up to an

New yorkUnited statesElyse freemanBroadridge financial solutionsJp morgan securitiesAllen companyPrnewswire recursion pharmaceuticals incExchange commissionProspectus departmentGoldman sachs coRecursion pharmaceuticalsNasdaq global select marketKeybanc capital marketsGoldman sachsIsland avenueRecursion operating system